arrow
G

Gábor Széplaki

Mater Private Hospital
H指数:27
被引数:2,751

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

First Multicentre Experience With the Seq2 Sequence of the Variable Loop Circular Catheter: Insights from VARIPURE

首次多中心使用可变环状消融导管Seq2序列的经验:来自VARIPURE的见解

2026-10-220
OAAI
Pulsed Field Ablation as First-Line Therapy for the Treatment of Atrial Fibrillation: a FARADISE Sub-Analysis

脉冲场消融作为心房颤动治疗的一线疗法:一项FARADISE亚组分析

2026-10-140
OAAI
Pulsed field ablation with a variable loop circular catheter in atrial fibrillation: Acute outcomes from the VARIPURE multicenter study

使用可变环状导管进行脉冲场消融治疗心房颤动:VARIPURE多中心研究的急性结果

2026-07-020
OAAI
Integrated Mapping-Guided Superior Vena Cava Isolation with Single-Shot Pulsed Field Ablation Systems: Feasibility, Workflow, and Safety in a Real-World Patient Cohort

集成基于映射引导的上腔静脉隔离与单次脉冲场消融系统:在真实世界患者队列中的可行性、工作流程与安全性

2026-02-230
OAAI
Dual energy for pulmonary vein isolation using focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 12-month results

双能量用于肺静脉隔离:采用集成了三维标测系统的焦点消融技术的SmartfIRE 12个月结果

2025-09-010
OA
Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry

真实世界中使用五尖波脉冲场消融系统的经验:FARADISE注册研究的一年结果

2025-09-010
OAAI
Comparative analysis of therapeutic strategies in atrial fibrillation patients with left atrial appendage thrombus despite optimal NOAC therapy

左心耳血栓患者中房颤患者治疗策略的对比分析,尽管接受了最佳NOAC治疗

2025-05-060
OA
Symptom burden, coagulopathy and heart disease after acute SARS-CoV-2 infection in primary practice

急性SARS-CoV-2感染后的症状负担,凝血病和心脏病

2024-09-110
OAAI
Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

17,000例以上心房颤动患者脉冲场消融安全性的MANIFEST-17K研究

2024-07-0822
OA
Dual energy for pulmonary vein isolation using dual-energy focal ablation technology integrated with a three-dimensional mapping system: SmartfIRE 3-month results

使用与三维标测系统集成的双能局灶性消融技术进行肺静脉隔离的双能: SmartfIRE 3个月的结果

2024-05-022
OAAI